HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Duration of positive urine for cocaine metabolite after ophthalmic administration: implications for testing patients with suspected Horner syndrome using ophthalmic cocaine.

AbstractPURPOSE:
To determine the duration of positive urine for benzoylecgonine, the major metabolite excreted in the urine, after topical ophthalmic administration of cocaine as one would perform for testing the presence of Horner syndrome.
METHODS:
Two drops of cocaine 10% were applied to each eye of 50 normal subjects. Urine samples were collected 4 to 6, 24, 48, 72, and 96 hours later. Each sample was assayed for benzoylecgonine using a screening competitive enzyme donor immunoassay followed by a highly specific and sensitive confirmatory gas chromatography-mass spectrometry assay. We employed assays and cutoff levels that fulfilled guidelines required by the Substance Abuse and Mental Health Services of the United States Department of Health and Human Services to mimic measures that exist for federal workplace drug testing.
RESULTS:
Of the 50 subjects, there were 25 women and 25 men, ranging in age from 19 to 59 years (median age, 40 years). Positive screening samples were obtained in 47 of 50 subjects (94%) 4 to 6 hours, 35 of 50 (70%) 24 hours, and 1 of 50 (2%) 48 hours after topical application of cocaine. None of the samples tested positive at 72 hours or beyond. Using the confirmatory assay's cutoff as the gold standard for a positive test, the sensitivity of the screening assay was 96% 4 to 6 hours, 90% 24 hours, and 14% 48 hours after topical application. Urine benzoylecgonine concentration was negatively correlated with body mass index and positively correlated with urine creatinine concentration.
CONCLUSIONS:
Patients should be informed that their urine may test positive for cocaine, if assayed according to US federal guidelines and using the protocol employed in this study, up to 2 days after undergoing testing for Horner syndrome.
AuthorsD M Jacobson, R Berg, G F Grinstead, J R Kruse
JournalAmerican journal of ophthalmology (Am J Ophthalmol) Vol. 131 Issue 6 Pg. 742-7 (Jun 2001) ISSN: 0002-9394 [Print] United States
PMID11384570 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Ophthalmic Solutions
  • Sympathomimetics
  • benzoylecgonine
  • Cocaine
Topics
  • Adult
  • Cocaine (administration & dosage, analogs & derivatives, urine)
  • Female
  • Gas Chromatography-Mass Spectrometry
  • Horner Syndrome (diagnosis, urine)
  • Humans
  • Immunoenzyme Techniques
  • Male
  • Middle Aged
  • Ophthalmic Solutions
  • Osmolar Concentration
  • Sympathomimetics (administration & dosage)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: